MedTrace Logo

Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease

NCT01602419 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-01-19

Study results available
· View outcomes & findings →

Summary

This is an observational study, hence there is no study hypothesis

Conditions

  • Von Willebrand Disease

Interventions

OTHER

Patients using Wilate as standard of care

Patients with von Willebrand Disease using Wilate for a period of 2 years.

Sponsors & Collaborators

  • Octapharma

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • United States
  • Argentina
  • Canada
  • Czechia
  • Germany
  • Portugal
  • Spain
  • Sweden
  • United Kingdom
  • Uruguay

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01602419 on ClinicalTrials.gov